These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23441114)

  • 1. In vitro effects of verteporfin on ocular cells.
    Ammar DA; Kahook MY
    Mol Vis; 2013; 19():424-9. PubMed ID: 23441114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aflibercept on the viability and metabolism of ocular cells in vitro.
    Ammar DA; Mandava N; Kahook MY
    Retina; 2013 May; 33(5):1056-61. PubMed ID: 23266881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro.
    Obata R; Iriyama A; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y
    Br J Ophthalmol; 2007 Jan; 91(1):100-4. PubMed ID: 16987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
    Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells.
    Huang Y; Obana A; Gohto Y; Nakajima S
    Lasers Surg Med; 2004; 34(3):216-26. PubMed ID: 15022248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model.
    Mennel S; Peter S; Meyer CH; Thumann G
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1015-21. PubMed ID: 16421742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
    Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
    Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.
    Chan WM; Lam DS; Lai TY; Tam BS; Liu DT; Chan CK
    Br J Ophthalmol; 2003 Dec; 87(12):1453-8. PubMed ID: 14660450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
    Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
    Celli JP; Solban N; Liang A; Pereira SP; Hasan T
    Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
    Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.
    Haimovici R; Kramer M; Miller JW; Hasan T; Flotte TJ; Schomacker KT; Gragoudas ES
    Curr Eye Res; 1997 Feb; 16(2):83-90. PubMed ID: 9068937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial.
    Kaiser PK;
    Curr Med Res Opin; 2009 Aug; 25(8):1853-60. PubMed ID: 19530976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization.
    Lu F; Hu Z; Sinard J; Garen A; Adelman RA
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3890-6. PubMed ID: 19357351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.
    Kim JW; Jacobsen B; Zolfaghari E; Ferrario A; Chevez-Barrios P; Berry JL; Lee DK; Rico G; Madi I; Rao N; Stachelek K; Wang LC; Gomer C
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2363-2373. PubMed ID: 28971251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
    Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.